Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening and Genetic Monitoring of Patients With MDS Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells

NCT01355913 is registered in ClinicalTrials.gov with Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH as lead sponsor.

NCT NCT01355913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01355913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening and Genetic Monitoring of Patients With MDS Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells
Lead sponsor
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
Phase
Observational
Overall status
Completed
Start date
October 31, 2008
Completion date
October 31, 2019
Enrollment
402 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

chromosmal aberrations, cytogenetic monitoring, karyotype evolution, myelodysplastic syndromes (mds), rare abnormalities